Back to 
Beacon Pointe Advisors, LLC
Beacon Pointe Advisors, LLC
IBRX
12 quarters
Position history for Beacon Pointe Advisors, LLC's holdings in ImmunityBio, Inc.
Yes. Beacon Pointe Advisors holds 73,497 shares of IBRX (ImmunityBio), worth $643,467, as of its Q2 2026 13F filing. It increased the position by 33,270 shares (+82.7%) from Q1 2026. Beacon Pointe Advisors has held IBRX since Q3 2023, across 12 quarterly 13F filings.
Current Value
$643,467
Current Shares
73,497
Total Value Change
+$599,456
Total Shares Change
+47,455
Quarter-by-Quarter History
Other major holders of IBRX: BlackRock, Inc., State Street Corp., Vanguard Portfolio Management LLC, Vanguard Capital Management LLC